Therapy-related acute myeloid leukemia/myelodysplasia with balanced 21q22 translocations

American Journal of Clinical Pathology

Volumn 117, Issue 2, 2002, Pages 306-313

  Arber, Daniel A ^a   Slovak, Marilyn L ^a   Popplewell, Leslie ^a   Bedell, Victoria ^a   Ikle, David ^a   Rowley, Janet D ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

21q22; Acute myeloid leukemia; AML 1; Myelodysplasia; Therapy related disease

Indexed keywords

CD19 ANTIGEN; CD34 ANTIGEN; CD56 ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ANTIGEN EXPRESSION; ARTICLE; BLAST CELL; CELL GRANULE; CHROMOSOME 21Q; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; CYTOPLASM; DISEASE ASSOCIATION; DYSPLASIA; EOSINOPHIL; HUMAN; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MORPHOLOGY; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROMYELOCYTE;

EID: 0036320256     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/C3G2-CXA0-HE9J-TKDR     Document Type: Article

References (20)

1. Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype
2. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: A Southwest Oncology Group/Eastern Cooperative Oncology Group Study
3. Associations between morphology, karyotype, and clinical features in myeloid leukemias
4. Morphological subtyping of acute myeloid leukemia with maturation (AMLM2): Homogeneous pink-colored cytoplasm of mature neutrophils is most characteristic of AML-M2 with t(8;21)
5. Correlation between cell morphology and expression of the AML1/ETO chimeric transcript in patients with acute myeloid leukemia without the t(8;21)
6. Presence of t(8;21)(q22;q22) in myeloperoxidase-positive, myeloid surface antigen-negative acute myeloid leukemia
7. Phenotypical characteristics of acute myelocytic leukemia associated with the t(8;21)(q22;q22) chromosomal abnormality: Frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34
8. Distinctive immunophenotypic features of t(8;21)(q22;q22) acute myeloblastic leukemia in children
9. Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21)(q22;q22)
10. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting - Airlie House, Virginia, November 1997
11. Realistic pathologic classification of acute myeloid leukemias
12. Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure
13. Topoisomerase II inhibitors induce DNA double-strand breaks at a specific site within the AML1 locus
14. Chromosomal abnormalities in secondary MDS and AML: Relationship to drugs and radiation with specific emphasis on the balanced rearrangements
15. Therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous stem cell transplantation
16. T(3;21)(q26;q22): A recurring chromosomal abnormality in therapy-related myelodysplastic syndrome and acute myeloid leukemia
17. 21q22-balanced chromosomal aberrations in therapy-related hematopoietic disorders: Report from an International Workshop
18. Transcriptionally active chimeric gene derived from the fusion of the AML1 gene and a novel gene on chromosome 8 in t(8;21) leukemic cells
19. The AML1-ETO chimaeric transcription factor in acute myeloid leukaemia: Biology and clinical significance
20. Acute myeloid leukemias